SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-037702
Filing Date
2023-10-19
Accepted
2023-10-19 16:15:23
Documents
33
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 408305
2 ex31-1.htm EX-31.1 14509
3 ex32-1.htm EX-32.1 6956
  Complete submission text file 0001493152-23-037702.txt   1776950

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE glsi-20230930.xsd EX-101.SCH 11805
5 XBRL CALCULATION FILE glsi-20230930_cal.xml EX-101.CAL 19253
6 XBRL DEFINITION FILE glsi-20230930_def.xml EX-101.DEF 41532
7 XBRL LABEL FILE glsi-20230930_lab.xml EX-101.LAB 126629
8 XBRL PRESENTATION FILE glsi-20230930_pre.xml EX-101.PRE 94904
27 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 150984
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 231334882
SIC: 2834 Pharmaceutical Preparations